No insider purchase over the last 90 days. The latest, by Huang Yu, was filed 02 Jan 2019.
Kontafarma China Holdings Ltd.: what insiders have been doing
Kontafarma China Holdings Ltd. is a listed company. Its insiders report their share dealings to HKEX. No insider at Kontafarma China Holdings Ltd. has published a filing in the past twelve months. The most recent one dates from 24 July 2020.
Over the whole record (from 2017), the tally stands at 7 purchases and 5 sales.
For comparison within the same market, see the insider buying recorded at Sun Hung Kai Properties Ltd. and Xinyi Glass Holdings Ltd. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Top signal score 14 of 100
Buys €268,848n/a Sells
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 7,421 of 26,280 companies
62.5
score / 100
Value
96
Quality
30
FCF yld30%
Earn yld·
EV/EBITDA·
ROE-47%
Gross mgn56%
Net mgn-47%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.